Journal
CURRENT OPINION IN VIROLOGY
Volume 25, Issue -, Pages 113-118Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2017.07.026
Keywords
-
Categories
Funding
- Cancer Research Switzerland [KFS-3234-08-2013]
- Worldwide Cancer Research [14-1033]
- SPARKS [15UOZ01]
- KFSPMS
- KFSPHHLD of the University of Zurich
- Sobek Foundation
- Swiss Vaccine Research Institute
- Swiss National Science Foundation [310030_162560, CRSII3_160708]
- Sparks Charity [15UOZ01] Funding Source: researchfish
Ask authors/readers for more resources
It is essential for the human immune system to control Epstein Barr virus (EBV), because this common human gamma-herpesvirus efficiently spreads through the human population with more than 90% being persistently infected after 20 years of age even in developed countries. Moreover, it threatens each host with its potent growth transforming properties, readily immortalizing human B cells into persistently growing lymphoma cell lines. Since this virus only infects humans, mice with reconstituted human immune system components provide an informative in vivo model to study EBV infection, the associated tumor formation and immune control thereof. They recapitulate the different infection programs in human B cells, allow modeling EBV driven lymphoma formation and interrogation of the key cytotoxic lymphocyte responses that are also required to control this pathogen in humans. The respective lessons that were taught by these investigations will be discussed in this review as well as the challenges in the future to address the whole portfolio of EBV associated diseases and how they could be prevented by EBV specific immunotherapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available